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The PROMIS GH is comprised of 10 global items that each represent a different domain of health. 10 Mental health and physical health summary scores are computed and standardized to the general population. Both these component scores and individual global items can be used to assess patients' perceptions of their health. PROMIS GH was chosen because of its ability to assess multiple outcome domains of stroke considered important by the expert panel and its low administration burden. The authors of the ICHOM consensus statement note that their recommendations are derived from expert consensus and that the PROMIS GH must be field tested using rigorous evaluation criteria. Indeed, there are sparse data, if any, on PROMIS GH in patients with stroke. It is necessary to assess the performance of PROMIS GH in patients with stroke before it is broadly implemented.
The primary objective of this study was to evaluate the psychometric properties of PROMIS GH in patients with ischemic stroke and intracerebral hemorrhage (ICH). A secondary objective was to compare the performance of PROMIS GH with PROMIS domain scales measuring similar constructs.
Methods
Study Design
De-identified data from this study will be made available to other researchers on request. We performed a retrospective cohort study of patients with stroke seen in the Cleveland Clinic Cerebrovascular Center who completed PROMIS GH from October 12, 2015, through June 2, 2017. Some patients were seen in consultation for a previous stroke event or for postdischarge follow-up after a recent stroke admission. Others were established patients seen for continued recurrent stroke prevention management. As part of routine care, both patient and clinician-reported scales are collected through the Knowledge Program-an electronic platform for systematic collection of patient-reported information. 11 PROMs are administered on tablets at the time of their ambulatory visit or through the electronic health record patient portal (MyChart, Epic Systems) before their appointment. Clinicians completed the National Institutes of Health stroke scale 12 and mRS 13 during each visit and recorded the date of the last stroke event. All providers have undergone standardized training and are certified in the completion of mRS, 14 which has been shown to improve interobserver reliability. 15 We used the standard mRS rather than the simplified version included in ICHOM stroke outcome measure set-our study objective was to evaluate the PROMIS GH only, and the mRS is more commonly used. 16 This study was approved by the Cleveland Clinic Institutional Review Board. Requirement for informed consent was waived.
Patients were included in the study cohort if they were ≥18 years of age, completed PROMIS GH during their visit, had a diagnosis of ischemic stroke or ICH obtained from either visit diagnosis codes (International Classification of Diseases Clinical Modification codes Ninth edition: 431, 433.x1, 434.x1, 433.91, and 436 and 10 th edition: I61x, I63xx), or provider documentation of ischemic stroke or ICH in structured fields of the Knowledge Program. Patients with history of subarachnoid hemorrhage were excluded. For patients who had >1 visit during the study period, scores from the first visit were used.
Patient-Reported Outcome Measures
PROMIS GH has been routinely completed in patients seen in the cerebrovascular center since October 2015. Nine of the 10 PROMIS GH items are scored on a Likert scale from 1 to 5, with 5 representing the best health. Pain is scored from 0 to 10 but was rescored to the 5-point scale as recommended. PROMIS GH produces 2 component scores: global physical health and global mental health. 10 The physical component scale (PCS) comprises 4 items on physical health, physical functioning, pain intensity, and fatigue, whereas the mental component scale (MCS) includes 4 items on overall quality of life, mental health, satisfaction with social activities and relationships, and emotional problems (Table I in the online-only Data Supplement) . Two PROMIS GH items (general health and social roles) are not used to calculate the physical and mental component scores. Component scores are centered on the 2000 United States Census with respect to age, sex, education, and race/ethnicity and are transformed to a T-score metric with a mean of 50 and SD of 10.
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In addition to PROMIS GH, the NeuroQoL v2.0 executive function scale and 6 PROMIS v1.0 domain scales were completed by patients: physical function, satisfaction with social roles, fatigue, anxiety, pain interference, and sleep disturbance. The PROMIS 18 and NeuroQoL 19 scales are closely related validated systems of tools developed using item response theory that assess different domains of self-reported health and have been previously used in stroke. 20, 21 These scales use computer-adaptive testing, which maximizes information obtained about the patient's status by administering questions to the patients based on their responses to previous items until a prespecified standard error is reached. In addition, established patients answered questions on impression of change across 6 PROMIS/NeuroQoL domains: physical functioning, social satisfaction, executive functioning, pain, fatigue, and anxiety. Lastly, patients completed the Patient Health Questionnaire 9-a 9-item depression screen frequently used in stroke and other patient populations that ranges from 0 to 27, with higher scores indicating more depressive symptoms. 22 The Patient Health Questionnaire 9 score was cocalibrated to the PROMIS metric providing equivalent PROMIS depression scores. 23 Patient demographics were obtained from the electronic health record. Approximate household income was estimated by Zone Improvement Plan (ZIP) code based on 2010 census data.
Statistical Analysis
The validity of the PROMIS GH summary component scores and item scores was evaluated in our population of patients with ischemic and hemorrhagic strokes. Patient characteristics are presented using descriptive statistics. Acceptability was assessed by calculating the frequency and proportion of missing responses to each item. 24 
Internal Reliability
Using the R package Lavaan, we investigated the existence of an underlying construct composed of 2 dimensions (MCS and PCS) through confirmatory factor analysis with weighted least squares. Model goodness-of-fit was assessed using the comparative fit index, root mean square error of approximation, and standardized root mean square residual, with values >0.90, <0.08, and <0.05 indicating excellent model fit, respectively. 25 Factor loadings with statistical significance were calculated. After evaluation of model fit, internal consistency was evaluated for each construct via ordinal α using the R package psych. Values ≥0.7 reflect good reliability. 24 Ordinal α more accurately estimates reliability for data on a Likert scale as compared with the more widely used Cronbach α.
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Convergent and Divergent Validity
Convergent validity was evaluated by comparing PROMIS GH summary scores and item responses to PROMIS domain scales, mRS, and National Institutes of Health stroke scale using polychoric, Pearson, or Spearman correlation coefficients, as appropriate. By convention, correlation coefficients of ≥0.30 and ≥0.50 represent medium and large correlations, respectively. 27 We hypothesized that correlation coefficients would be highest between global health items and PROMIS domain scales measuring the same construct. We also anticipated that correlation coefficients between global health items and PROMIS domain scales measuring the same or related constructs would be higher than those between global health items and PROMIS domain scales measuring dissimilar constructs ( Table I in the onlineonly Data Supplement). Divergent, or discriminant, validity was conducted comparing scores of patients across varying stroke severity, as defined by mRS 0 through 5. Patients with mRS scores of 4 and 5 were grouped because of the small sample size of patients with severe stroke. Differences across mRS category were assessed using Kruskal-Wallis test. Cohen d effect sizes for scores were calculated between stroke severity, as measured by mRS scores <2 versus ≥2. Values >0.2, >0.5, and >0.8 represent small, moderate, and large effects, respectively. 28, 29 The divergent validity of PROMIS domain scores as compared with PROMIS GH items were evaluated for scores measuring similar constructs. Effect sizes were compared using Fisher z test.
Subgroup Analyses
Test-retest reliability and responsiveness to change were evaluated in a subset analysis of patients with at least 2 visits during the study period. If scores from >2 visits were available, the closest visit in time was taken. Patient characteristics were compared between patients with only 1 visit versus patients with ≥2 visits using χ 2 test or Fisher exact test (for small cell size) for categorical variables and t test or Mann-Whitney U test (nonparametric) for continuous variables. Change was determined from patient response to perceived global impression of change questions on similar constructs. Responses from impression of change in the physical function domain were used to categorize patient response to PROMIS GH items 1 (general health), 3 (physical health), and 6 (physical activities). Perceived global impression of change on the social satisfaction domain was used to assess change to items 2 (quality of life), 5 (social satisfaction), and 9 (social activities). Perceived change in executive functioning was used for item 4 (mental health). Perceived change in the domain of pain was used for item 7 (pain), fatigue for item 8 (fatigue), and anxiety for item 10 (emotional problems).
Test-Retest Reliability
Because this study was not constructed to assess test-retest reliability, a subset of patients who were not expected to display change were identified to provide an estimate of test-retest reliability. Scores were compared between patients with at least 2 visits within a 6-month time period who indicated no change on perceived global impression of change questions. Weighted κ statistics with 95% confidence intervals (CIs) were used to measure test-retest reliability for all PROMIS GH items. Values 0.41 to 0.60, 0.61 to 0.80, and >0.81 represent moderate, substantial, and excellent agreement, respectively. 30 Intraclass correlation coefficients as defined by Shrout and Fleiss 31 (3,1) were used to compare component scores.
Responsiveness
For evaluating responsiveness, patient responses on perceived global impression of change questions were used to indicate improvement versus worsening based on the 6 domains. Patient responses of minimally improved, much improved, and very much improved were used to classify improvement, whereas responses of minimally worse, much worse, and very much worse denoted worsening. Mean change in PROMIS GH item and summary scores was calculated within patients who improved versus worsened, and responsiveness was further assessed using Cohen d effect size for prepost design with 95% CIs.
Responsiveness of PROMIS domain scales as compared with PROMIS GH items was evaluated for scores measuring similar constructs. Effect sizes were compared using Fisher z test.
Sensitivity Analyses
Subgroup analyses were conducted to evaluate whether PROMIS GH items demonstrated measurement invariance across stroke subtype and severity. All reliability and validity analyses stated above were replicated stratified by patients with ischemic versus hemorrhagic stroke, as well as by Rankin Scale score <2 versus ≥2.
Despite the large number of tests performed, the focus of the analysis was on effect size and clinical relevance. As such, there was no formal adjustment for multiplicity, and statistical significance was established throughout at P<0.05. All data analyses were performed using SAS 9.4 statistical software (SAS, Inc, Cary, NC) and R version 3.2.4.
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Results
There were 1102 patients with stroke seen in Cleveland Clinic's cerebrovascular center who completed a PROMIS GH between October 12, 2015, and June 2, 2017. The majority of patients had an ischemic stroke (n=951; 86.3%), 138 (12.5%) had an ICH, 13 (1.2%) had both, and 38 (3.4%) patients had a concomitant transient ischemic attack. Average age was 60.8 (±14.9) years, with 509 (46.2%) women and a median household income of $50 097 ( Table 1 ). The median time since last stroke was 134 days (interquartile range, 47-540). The majority of patients (n=676; 65.1%) had mild disability defined by mRS scores 0 to 1, 363 (34.9%) had moderate to severe disability (mRS, ≥2). Patients required help completing questionnaires from caregivers in 28.4% of visits.
Acceptability, defined by completeness of the responses to the PROMIS GH questions, was exceptionally high, with <1% missingness across 9 of the 10 items (Table II in the onlineonly Data Supplement). The pain question was skipped the most by patients (n=35; 3.18%). Because of the high response rate of all items comprising the MCS, the component score 
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was available on all but 4 patients (99.64%). A total of 1062 (96.37%) patients completed all items comprising the physical component score.
Internal Reliability
Results of the confirmatory factor analysis are shown in the Appendix (Table III in the online-only Data Supplement). The 2-factor solution indicated acceptable goodness-of-fit as assessed by the comparative fit index and the standardized root mean square residual; however, the root mean square error of approximation was 0.11 (95% CI, 0.10-0.13), well above the acceptable cutoff of 0.08. All factor loadings were statistically significant at P<0.001 and indicated moderate association with the factor. Emotional problems had the lowest factor loading with MCS, and pain had the lowest with PCS. Internal consistency reliability was assessed using ordinal α coefficient. MCS and PCS had ordinal α of 0.875 and 0.823, respectively, indicating good reliability.
Convergent and Divergent Validity
Correlations between items are shown in the heat map in Figure 1 . All items exemplified significantly high correlation with one another (P<0.0001 for all comparisons). As evidenced by the lower internal reliability in the PCS, measures that make up the physical component score are less highly correlated with each other than the measures that make up the mental component score.
Convergent validity was demonstrated through significant correlations between all PROMIS GH items and summary scores with both patient-reported and provider-reported outcomes (P<0.001 for all; Table 2 ). Consistent with our hypothesis, for each individual PROMIS GH item except for social satisfaction with social relationships and activities, correlation was highest with the PROMIS domain scale or scales measuring the same constructs. The PROMIS GH items 6 (physical activities), 7 (pain), and 8 (fatigue) measured the same construct as the PROMIS domain scales physical function, pain interference, and fatigue, respectively, and these had correlations of ≥0.76. In addition, the correlation coefficients between PROMIS GH items and PROMIS domain scales measuring related constructs were higher than those between PROMIS GH items and PROMIS domain scales measuring dissimilar constructs. For all PROMIS GH items and component scores, correlations were lowest with provider-reported National Institutes of Health Stroke Scale and mRS scores. Provider-reported scales were the most strongly correlated with physical activities (r=−0.48 to −0.37, respectively) and the least strongly correlated with pain (r=−0.16 to −0.11).
Discriminant validity is shown in Table 3 . All 10 items and both component scores demonstrate excellent discrimination across levels of severity, as measured by the provider-reported mRS score (P<0.001 for all). Item response on physical activities question indicated the strongest dose-response relationship with mRS score, whereas emotional problems had the weakest association.
Discriminant validity was compared between PROMIS domain scales and PROMIS GH items for measures assessing the same or similar constructs (Table IV in the online-only Data Supplement). Effect sizes for scores differentiating between stroke severity (mRS, <2 versus ≥2) were high for PROMIS domains physical functioning (1.03; 95% CI, 0.90-1.17) and satisfaction with social roles (0.77; 95% CI, 0.63-0.90). Effect sizes were moderate for similar PROMIS GH items assessing these constructs but were significantly lower for items 1 (general health), 3 (physical health), and 5 (social satisfaction) as compared with their similar PROMIS domain scale counterparts. Pain, fatigue, and anxiety/emotional problems demonstrated smaller effect sizes for discriminating between stroke severities, and there was not a significant difference between these item scores and corresponding domain scales.
Subgroup Analyses
Test-retest reliability and responsiveness were assessed within a subset of patients who completed PROMs on at least 2 visits. Patient characteristics were similar between this subset of 195 patients and the total study cohort (data not shown).
Test-Retest Reliability
Responses on all PROMIS GH items and component scores were significantly associated with their prior responses (correlation coefficients ≥0.80 for all but fatigue [r=0.78] and emotional problems [r=0.50]; Table V in the online-only Data Supplement). For all items except emotional problems, weighted κ scores were in the moderate-substantial agreement range (range from κ=0.54 for pain to κ=0.72 for physical health). Emotional problems showed fair agreement (κ=0.39; 95% CI, 0.19-0.60). The intraclass coefficients for mental and physical summary scores indicated strong agreement (intraclass correlation coefficients (3,1), 0.86, and 0.88, respectively). Figure 2 . In patients who indicated they were minimally improved, much improved, and very much improved from their last visit, there was an improvement in all items, which was statistically significant for the PROMIS GH items physical health, physical activities, mental health, pain, fatigue, emotional problems, and the summary scores. In patients who specified worsening on domain-specific scales, responses were lower on all items but pain, although, because of limited sample size, none reached statistical significance. Effect sizes were moderate or larger (≥0.50) for all items but quality of life (0.43; 95% CI, −0.05 to 0.92) and pain (0.30; 95% CI, −0.13 to 0.73).
Responsiveness
Responsiveness of the PROMIS GH items is shown in
Responsiveness to change by items was also compared with PROMIS domain scales measuring similar constructs (Table VI in the online-only Data Supplement). All PROMIS domain scales showed strong responsiveness to improvement versus worsening (effect size, >0.76) with the exception of pain interference (effect size, 0.41; 95% CI, −0.02 to 0.84). The PROMIS domain of satisfaction with social roles had a significantly larger effect size as compared with PROMIS GH items measuring similar constructs (quality of life, social satisfaction, and social activities). 
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Sensitivity Analyses
Subgroup analyses confirmed that PROMIS GH items demonstrate measurement invariance across stroke subtype and severity. All reliability and validity analyses stated above were replicated stratified by patients with ischemic versus hemorrhagic stroke, as well as by Rankin Scale score <2 versus ≥2. Results show similar levels of reliability and convergent and discriminant validity. In stroke subtypes, similar responsiveness was demonstrated in ischemic patients (data not shown, available on request). There were too few patients with ICH with repeat visits to determine responsiveness or test-retest reliability.
Discussion
In this large retrospective cohort study of patients with stroke, PROMIS GH demonstrated acceptable performance when compared with 6 PROMIS scales measuring similar constructs, supporting its use in the assessment of health status in patients with stroke. Findings were similar in patients with both ischemic stroke and ICH. The ability to use PROMIS GH to measure outcomes after stroke brings several advantages. Because it is a generic measure, comparisons can be made across populations of patients with different conditions. PROMIS GH has been collected as part of the National Health Interview Survey since 2010, will be included in Healthy People 2020, 33 and is being collected in several hospital systems (Katzan, personal communication) . With the rapidly increasing use of PROMIS GH, comparative populations will become more readily available. The PROMIS GH component scores are normed to the US general population, aiding score interpretation. In addition, a health utility index can be estimated from the PROMIS GH, 34 which can be used to estimate disease burden and used in cost-effectiveness analyses.
Global health measures, such as the PROMIS GH, are a type of PROM that consist of single items that each represent a different domain of health. 10 The brevity of global health measures increases the feasibility of routine administration. However, the use of a single item to assess each health construct may reduce the precision and responsiveness of measurement. The results of our study indicate that PROMIS GH items and component scores discriminate well across levels of disability as defined by the mRS. Our analyses also provided data suggesting reasonable responsiveness of 8 of the 10 individual items in an analysis using patients' impression of improvement/worsening as clinical anchors for change. Not surprisingly, the responsiveness of the PROMIS domain scores tended to be higher with greater effect sizes than the individual PROMIS GH items. However, this difference was significant only for PROMIS domain satisfaction with social roles, compared with PROMIS GH items measuring the same or similar constructs. The patient questions on impression of improvement/worsening were worded to correspond with the domains assessed by the PROMIS scales rather than the individual PROMIS GH items, which likely impacted the responsiveness of several of the PROMIS GH items (general health, physical health, quality of life, satisfaction with social activities, mental health, and emotional problems) that did not specifically match the PROMIS domains.
Test-retest reliability was high for all items but emotional problems. Emotional problems displayed the highest level of responsiveness, so test-retest reliability may be biased in this item.
The study also demonstrated good convergent validity, which was assessed by measuring correlations between scores of different PROMIS scales. As expected, the highest correlations were seen between individual items of PROMIS GH and PROMIS scales measuring the same constructs, and the lowest correlations were seen between PROMIS GH items and PROMIS scales measuring dissimilar constructs. Item-scale correlations of PROMIS GH and PROMIS scales compared favorably with the validation study of PROMIS GH, which included a community sample representative of national norms 17 and a clinical sample of patients with different conditions, such as heart disease, cancer, osteoarthritis, psychiatric disorders, and chronic obstructive pulmonary disease. 10 Importantly, analysis of the component scores demonstrates poor model fit with summarizing items into 2 factors (root mean square error of approximation, >0.11) and only moderate internal reliability (ordinal α values, <0.9). These findings suggest that greater focus should be placed on individual PROMIS GH items than on the component scores when assessed in patients with stroke.
An important strength of this study was the concomitant collection of different PROMIS scales, which allowed us to assess the convergent validity of the individual PROMIS GH items and compare the responsiveness and discriminant validity with the PROMIS scales that measured same/ similar domains. Impression of change questions for different domains provided a clinical anchor for assessment of responsiveness. Additional strengths of this study are the large sample size and the collection of these scales in a real-world population at the point of care, which is the ultimate goal of ICHOM standard set.
A limitation of this analysis is the overall mild degree of disability of patients in the study cohort. However, reliability, convergent validity, and test-retest reliability were similar in subgroup of patients with moderate-severe disability (mRS, ≥2). The study cohort consisted of patients from an urban setting in the United States and is not representative of all patients with stroke seen in different countries and care settings. Another limitation was that not all patients with stroke seen in the cerebrovascular clinic had the entire set of routinely completed functional status scales reported by the patient and clinician. Finally, there were limited follow-up data for assessing responsiveness, and few patients (n<20) indicated worsening. Given this, the results of the analyses on responsiveness should be considered as preliminary.
In conclusion, PROMIS GH exhibits acceptable performance in patients with ischemic and hemorrhagic stroke. The results of our study support the recommendation from ICHOM to use PROMIS GH as part of the standard set of outcome measures in stroke. Because of the moderate internal reliability and poor model fit of summarizing items into physical and mental health component scores, greater focus should be placed on individual PROMIS GH items than on the component scores in patients with stroke. Collection of PROMIS scales, if feasible in clinical practice, may provide more precise assessment of patient-reported outcomes. Further evaluation of the responsiveness of PROMIS GH individual items over time is warranted for patients with stroke and other conditions.
